title: Functional correlates of exaggerated oscillatory activity in basal ganglia output in hemiparkinsonian rats.
abstract: Exaggerated beta range (13-30Hz) synchronized activity is observed in the basal ganglia of Parkinson's disease (PD) patients during implantation of deep brain stimulation electrodes and is thought to contribute to the motor symptoms of this disorder. To explore the translational potential of similar activity observed in a rat model of PD, local field potentials (LFPs) and spiking activity in basal ganglia output were characterized in rats with unilateral dopamine cell lesion during a range of behaviors. A circular treadmill was used to assess activity during walking; hemiparkinsonian rats could maintain a steady gait when oriented ipsiversive to the lesioned hemisphere, but were less effective at walking when oriented contraversive to lesion. Dramatic increases in substantia nigra pars reticulata (SNpr) LFP oscillatory activity and spike-LFP synchronization were observed within the beta/low gamma range (12-40Hz) in the lesioned hemisphere, relative to the non-lesioned hemisphere, with the dominant frequency of spike-LFP entrainment and LFP power varying with behavioral state. At 3weeks postlesion, the mean dominant entrainment frequency during ipsiversive treadmill walking and grooming was 34Hz. Other behaviors were associated with lower mean entrainment frequencies: 27-28Hz during alert non-walking and REM, 17Hz during rest and 21Hz during urethane anesthesia with sensory stimulation. SNpr spike-LFP entrainment frequency was stable during individual treadmill walking epochs, but increased gradually over weeks postlesion. In contrast, SNpr LFP power in the 25-40Hz range was greatest at the initiation of each walking epoch, and decreased during walking to stabilize by 6min at 49% of initial values. Power was further modulated in conjunction with the 1.5s stepping rhythm. Administration of l-dopa improved contraversive treadmill walking in correlation with a reduction in SNpr 25-40Hz LFP power and spike synchronization in the dopamine cell lesioned hemisphere. These effects were reversed by the serotonergic 1A agonist, 8-OH-DPAT. While the prominent spike-LFP phase locking observed during ongoing motor activity in the hemiparkinsonian rats occurs at frequencies intriguingly higher than in PD patients, the synchronized activity in the SNpr of this animal model has much in common with oscillatory activity recorded from the basal ganglia of the PD patients. Results support the potential of this model for providing insight into relationships between synchronization of basal ganglia output induced by loss of dopamine and motor symptoms in PD.
authors.affiliation: Neurophysiological Pharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-3702, USA.
authors.forename: Elena
authors.initials: E
authors.lastname: Brazhnik
authors.affiliation: Neurophysiological Pharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-3702, USA.
authors.forename: Nikolay
authors.initials: N
authors.lastname: Novikov
authors.affiliation: Neurophysiological Pharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-3702, USA.
authors.forename: Alex J
authors.initials: AJ
authors.lastname: McCoy
authors.affiliation: Neurophysiological Pharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-3702, USA.
authors.forename: Ana V
authors.initials: AV
authors.lastname: Cruz
authors.affiliation: Neurophysiological Pharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-3702, USA. Electronic address: waltersj@ninds.nih.gov.
authors.forename: Judith R
authors.initials: JR
authors.lastname: Walters
mesh_terms: D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D018663:Adrenergic Agents / Q000633:toxicity; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D001479:Basal Ganglia / Q000503:physiopathology*; D058256:Brain Waves / Q000187:drug effects / Q000502:physiology*; D004195:Disease Models, Animal; D018492:Dopamine Antagonists / Q000494:pharmacology; D007839:Functional Laterality / Q000502:physiology*; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D009434:Neural Pathways / Q000293:injuries / Q000502:physiology; D016627:Oxidopamine / Q000633:toxicity; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology*; D010879:Piperazines / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D020318:Rats, Long-Evans; D012457:Salicylamides / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D013378:Substantia Nigra / Q000503:physiopathology
chemical_list: D018663:Adrenergic Agents; D000978:Antiparkinson Agents; D018492:Dopamine Antagonists; D010879:Piperazines; D011725:Pyridines; D012457:Salicylamides; D012702:Serotonin Antagonists; D007980:Levodopa; C090413:N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide; D016627:Oxidopamine; C045989:eticlopride
keywords: 6-Hydroxydopamine; Basal ganglia; Beta frequency; Dopamine; Gait; Local field potentials; Motor cortex; Oscillations; Parkinson's disease; Serotonin; Substantia nigra pars reticulata
references.citation: Front Comput Neurosci. 2013 Apr 25;7:39
references.pmid: 23630492
references.citation: Exp Neurol. 2010 Jan;221(1):260-6
references.pmid: 19944098
references.citation: J Neurosci. 2001 Feb 1;21(3):RC128
references.pmid: 11157099
references.citation: J Neurosci. 2008 Dec 24;28(52):14245-58
references.pmid: 19109506
references.citation: Eur J Neurosci. 2007 May;25(10):3137-45
references.pmid: 17561827
references.citation: Neuroimage. 2013 Feb 1;66:301-10
references.pmid: 23153964
references.citation: J Neurosci. 1995 May;15(5 Pt 2):3863-75
references.pmid: 7751951
references.citation: J Neurophysiol. 1994 Aug;72(2):507-20
references.pmid: 7983515
references.citation: Exp Neurol. 2008 Sep;213(1):108-13
references.pmid: 18619592
references.citation: Brain. 2007 Jul;130(Pt 7):1819-33
references.pmid: 17452372
references.citation: Cell Mol Neurobiol. 2002 Dec;22(5-6):611-32
references.pmid: 12585682
references.citation: Mov Disord. 2009 Jan 30;24(2):254-60
references.pmid: 18951542
references.citation: Eur J Neurosci. 2012 Jul;36(2):2229-39
references.pmid: 22805067
references.citation: Prog Brain Res. 2008;172:465-78
references.pmid: 18772046
references.citation: J Physiol. 2014 Apr 1;592(7):1429-55
references.pmid: 24344162
references.citation: Clin Neurophysiol. 2005 Nov;116(11):2510-9
references.pmid: 16029963
references.citation: J Neurosci. 2000 Nov 15;20(22):8559-71
references.pmid: 11069964
references.citation: J Pharmacol Exp Ther. 1999 Feb;288(2):820-6
references.pmid: 9918594
references.citation: Brain. 2006 Jul;129(Pt 7):1748-57
references.pmid: 16684788
references.citation: Brain. 2011 Feb;134(Pt 2):359-74
references.pmid: 21147836
references.citation: J Neurochem. 2001 Mar;76(5):1346-53
references.pmid: 11238719
references.citation: Neuron. 2012 Feb 9;73(3):523-36
references.pmid: 22325204
references.citation: Basal Ganglia. 2014 Apr 1;3(4):221-227
references.pmid: 25667820
references.citation: Neuroscience. 2012 Feb 17;203:1-11
references.pmid: 22209920
references.citation: Neuroscience. 2013 Jun 14;240:106-16
references.pmid: 23454540
references.citation: Brain. 2004 Apr;127(Pt 4):735-46
references.pmid: 14960502
references.citation: J Clin Invest. 2014 Mar;124(3):1340-9
references.pmid: 24531549
references.citation: Eur J Neurosci. 2012 Jul;36(2):2213-28
references.pmid: 22805066
references.citation: Ann Neurol. 2009 May;65(5):618; author reply 618-9
references.pmid: 19475660
references.citation: Ann N Y Acad Sci. 1990;600:93-103; discussion 103
references.pmid: 2123618
references.citation: Eur J Neurosci. 2005 Mar;21(5):1403-12
references.pmid: 15813950
references.citation: J Physiol. 2005 Oct 15;568(Pt 2):699-711
references.pmid: 16123109
references.citation: Brain. 2008 Dec;131(Pt 12):3380-94
references.pmid: 18952677
references.citation: J Neurosci. 2011 Jul 13;31(28):10311-22
references.pmid: 21753008
references.citation: Neurophysiol Clin. 2014 Jan;44(1):69-76
references.pmid: 24502907
references.citation: Exp Neurol. 2009 Feb;215(2):380-7
references.pmid: 19070616
references.citation: J Parkinsons Dis. 2013 Jan 1;3(3):241-54
references.pmid: 23948994
references.citation: Mov Disord. 2006 Oct;21(10):1566-77
references.pmid: 16830313
references.citation: Cereb Cortex. 2009 Jul;19(7):1616-30
references.pmid: 18996909
references.citation: J Neurosci. 2008 Apr 30;28(18):4795-806
references.pmid: 18448656
references.citation: Front Syst Neurosci. 2011 Jun 08;5:42
references.pmid: 21713126
references.citation: J Neurosci. 2006 Aug 2;26(31):8101-14
references.pmid: 16885224
references.citation: J Neurosci. 2002 Jun 1;22(11):4639-53
references.pmid: 12040070
references.citation: Eur J Neurosci. 2006 Apr;23(7):1956-60
references.pmid: 16623853
references.citation: Neurol Sci. 2002 Sep;23 Suppl 2:S101-2
references.pmid: 12548363
references.citation: Brain. 2009 Aug;132(Pt 8):2139-50
references.pmid: 19369488
references.citation: Brain Res. 2004 Mar 12;1000(1-2):183-91
references.pmid: 15053966
references.citation: J Neurophysiol. 2009 Sep;102(3):1811-20
references.pmid: 19625533
references.citation: Neurobiol Dis. 2012 Jul;47(1):38-48
references.pmid: 22465187
references.citation: Exp Neurol. 2004 Oct;189(2):369-79
references.pmid: 15380487
references.citation: Eur J Neurosci. 2005 Mar;21(5):1413-22
references.pmid: 15813951
references.citation: Brain Res. 2005 Jun 7;1046(1-2):230-3
references.pmid: 15894297
references.citation: Neuroimage. 2014 Jan 15;85 Pt 2:637-47
references.pmid: 23711535
references.citation: Neurobiol Dis. 2012 May;46(2):402-13
references.pmid: 22353564
references.citation: J Neurosci. 2012 Oct 3;32(40):13718-28
references.pmid: 23035084
references.citation: Eur J Neurosci. 2007 Sep;26(6):1701-13
references.pmid: 17880401
references.citation: Mov Disord. 2003 Apr;18(4):357-63
references.pmid: 12671940
references.citation: Exp Neurol. 2010 Feb;221(2):307-19
references.pmid: 19948166
references.citation: Parkinsonism Relat Disord. 2008;14 Suppl 2:S154-8
references.pmid: 18579429
references.citation: J Neurosci. 2001 Feb 1;21(3):1033-8
references.pmid: 11157088
references.citation: Eur J Neurosci. 2011 Nov;34(9):1470-84
references.pmid: 22034978
references.citation: Clin Neurophysiol. 2013 Mar;124(3):565-73
references.pmid: 23085388
references.citation: PLoS Comput Biol. 2011 Aug;7(8):e1002124
references.pmid: 21852943
references.citation: J Neurosci. 2012 Jun 6;32(23):7869-80
references.pmid: 22674263
references.citation: J Neurochem. 2010 Mar;112(6):1465-76
references.pmid: 20050978
references.citation: J Neurosci. 2002 Apr 1;22(7):2855-61
references.pmid: 11923450
references.citation: Neuroreport. 2011 Mar 9;22(4):151-6
references.pmid: 21304324
references.citation: Brain. 2002 Jun;125(Pt 6):1235-46
references.pmid: 12023312
references.citation: Science. 2001 Feb 23;291(5508):1560-3
references.pmid: 11222864
references.citation: Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11620-5
references.pmid: 21697509
references.citation: Neuroscience. 2011 Dec 15;198:54-68
references.pmid: 21723918
references.citation: Neuroimage. 2013 Mar;68:203-13
references.pmid: 23247184
references.citation: Exp Neurol. 2005 Jul;194(1):212-20
references.pmid: 15899258
references.citation: Exp Neurol. 2010 Jul;224(1):234-40
references.pmid: 20353774
references.citation: J Neurophysiol. 2007 Dec;98(6):3525-37
references.pmid: 17928554
references.citation: Neuroscience. 2007 Jan 19;144(2):762-76
references.pmid: 17112675
references.citation: J Neurophysiol. 2006 Dec;96(6):3248-56
references.pmid: 17005611
references.citation: Neurobiol Dis. 2013 Oct;58:242-8
references.pmid: 23727447
references.citation: J Neurosci. 2006 Mar 29;26(13):3567-83
references.pmid: 16571765
references.citation: Exp Neurol. 2006 Jan;197(1):244-51
references.pmid: 16289053
references.citation: Exp Neurol. 2013 Jul;245:52-9
references.pmid: 22921537
references.citation: J Theor Biol. 2009 Apr 21;257(4):664-88
references.pmid: 19154745
references.citation: Trends Neurosci. 2011 Dec;34(12):611-8
references.pmid: 22018805
references.citation: Neurobiol Dis. 2010 Apr;38(1):136-43
references.pmid: 20096781
references.citation: J Neurosci. 2001 Aug 15;21(16):6430-9
references.pmid: 11487667